Pharma Journalist - Page 53 of 946 -

Aurisco Passes FDA Inspection for Generic Oligonucleotide APIs

Alfasigma to Acquire Nordic Pharma in Global Expansion

Lilly Files Six Lawsuits Against Black-Market Retatrutide Sellers

FDA Approves Arrowhead’s REDEMPLO, the First siRNA Therapy for Familial Chylomicronemia Syndrome

EU Approves First Subcutaneous Version of Keytruda for All Adult Indications

LNP Innovation Surges as 5th LNP Summit Unveils 2026 Agenda

EU Approves First-Ever Treatment for Non-Cystic Fibrosis Bronchiectasis

FDA Approves AbbVie’s EPKINLY Combination for Relapsed or Refractory Follicular Lymphoma

Genprex Secures U.S. Patent Protecting REQORSA and PD-L1 Antibody Combination

J&J to Acquire Halda Therapeutics in $3.05B Cancer Therapy Deal

EMA Panel Backs High-Dose SPINRAZA Regimen for Spinal Muscular Atrophy

Johnson & Johnson to Acquire Halda Therapeutics for $3.05B to Expand Oncology Pipeline

Merus and Halozyme Partner to Develop Subcutaneous Version of Petosemtamab